September 9 , 2008
Fairmont Copley Plaza
Boston, Massachusetts
Key Decision-Making Strategies in Preclinical Drug Development
Mark LJ Reimer, Ph.D.
Senior Director, Preclinical Development, Pharsight Reporting and Analysis Services
View Presentation (sign-in required)
®
Regulatory Population Pharmacokinetics / Pharmacodynamics
Workflow ? The Pharsight Approach
Dan Weiner, Ph.D.
Senior Vice President and Chief Technology Officer, Pharsight
View Presentation (sign-in required)
Pharsight PK Accelerator and Automation of Reporting
Dan Weiner, Ph.D.
Senior Vice President and Chief Technology Officer, Pharsight
View Presentation (sign-in required) ![]()